New combo therapy aims to stop liver cancer from growing back
NCT ID NCT04996914
First seen May 12, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This study tests whether adding a precise, high-dose radiation treatment (SBRT) after a standard liver cancer procedure (TACE) can better control tumors that cannot be surgically removed. About 30 adults with early- to intermediate-stage liver cancer will receive the combination and be followed for one year to see if the treated tumors stop growing. The goal is to improve local control without requiring lifelong medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA NON-RESECTABLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RWTH Aachen University Hospital
RECRUITINGAachen, North Rhine-Westphalia, 52074, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.